Tiếp theo

Tự chạy

Dr. Brentjens on CD19-Targeted T Cells in CLL and ALL

2 Lượt xem • 07/14/23
Đăng lại
Nhúng
administrator
administrator
Người đăng ký
0

Renier J. Brentjens, MD, PhD, associate professor, chief, Cellular Therapeutics Center, Memorial Sloan-Kettering Cancer Center, discusses clinical responses in patients with chronic lymphoblastic leukemia (CLL) or acute lymphoblastic leukemia (ALL) following infusion with CD19-Targeted T Cells.

Cho xem nhiều hơn
0 Bình luận sort Sắp xếp theo
Bình luận trên Facebook

Tiếp theo

Tự chạy